NM_001854.4:c.3025-23A>T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001854.4(COL11A1):​c.3025-23A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 1,545,698 control chromosomes in the GnomAD database, including 8,988 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.080 ( 680 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8308 hom. )

Consequence

COL11A1
NM_001854.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.54
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but rather VUS (scored 5 / 10). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 1-102962288-T-A is Benign according to our data. Variant chr1-102962288-T-A is described in ClinVar as [Benign]. Clinvar id is 258454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A1NM_001854.4 linkc.3025-23A>T intron_variant Intron 39 of 66 ENST00000370096.9 NP_001845.3 P12107-1Q59HB5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A1ENST00000370096.9 linkc.3025-23A>T intron_variant Intron 39 of 66 1 NM_001854.4 ENSP00000359114.3 P12107-1

Frequencies

GnomAD3 genomes
AF:
0.0800
AC:
12164
AN:
152044
Hom.:
681
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0188
Gnomad AMI
AF:
0.264
Gnomad AMR
AF:
0.0523
Gnomad ASJ
AF:
0.144
Gnomad EAS
AF:
0.00405
Gnomad SAS
AF:
0.110
Gnomad FIN
AF:
0.150
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.111
Gnomad OTH
AF:
0.0712
GnomAD3 exomes
AF:
0.0927
AC:
23239
AN:
250790
Hom.:
1426
AF XY:
0.0984
AC XY:
13341
AN XY:
135534
show subpopulations
Gnomad AFR exome
AF:
0.0181
Gnomad AMR exome
AF:
0.0365
Gnomad ASJ exome
AF:
0.138
Gnomad EAS exome
AF:
0.00337
Gnomad SAS exome
AF:
0.120
Gnomad FIN exome
AF:
0.141
Gnomad NFE exome
AF:
0.114
Gnomad OTH exome
AF:
0.0989
GnomAD4 exome
AF:
0.104
AC:
145389
AN:
1393536
Hom.:
8308
Cov.:
23
AF XY:
0.106
AC XY:
73934
AN XY:
697688
show subpopulations
Gnomad4 AFR exome
AF:
0.0162
Gnomad4 AMR exome
AF:
0.0382
Gnomad4 ASJ exome
AF:
0.137
Gnomad4 EAS exome
AF:
0.00153
Gnomad4 SAS exome
AF:
0.124
Gnomad4 FIN exome
AF:
0.141
Gnomad4 NFE exome
AF:
0.110
Gnomad4 OTH exome
AF:
0.0999
GnomAD4 genome
AF:
0.0799
AC:
12162
AN:
152162
Hom.:
680
Cov.:
32
AF XY:
0.0816
AC XY:
6070
AN XY:
74378
show subpopulations
Gnomad4 AFR
AF:
0.0188
Gnomad4 AMR
AF:
0.0523
Gnomad4 ASJ
AF:
0.144
Gnomad4 EAS
AF:
0.00406
Gnomad4 SAS
AF:
0.110
Gnomad4 FIN
AF:
0.150
Gnomad4 NFE
AF:
0.111
Gnomad4 OTH
AF:
0.0705
Alfa
AF:
0.105
Hom.:
198
Bravo
AF:
0.0676
Asia WGS
AF:
0.0370
AC:
133
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 26, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Hearing loss, autosomal dominant 37 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Marshall syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Fibrochondrogenesis 1 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Stickler syndrome type 2 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
9.7
DANN
Benign
0.54
La Branchor
0.74
BranchPoint Hunter
5.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs55682104; hg19: chr1-103427844; API